产品详情
查看大图

  • 产品名称：Mitogen-ActivatedProteinKinaseKinaseKinase14(MAP3K14)(C-Term)Peptide

  • 产品型号：
  • 产品厂商：ProSci-Inc
  • 产品文档：
你添加了1件商品 查看购物车
简单介绍：
Mitogen-ActivatedProteinKinaseKinaseKinase14(MAP3K14)(C-Term)Peptide
详情介绍：
Blocked Antibody anti-MAP3K14 antibody (Mitogen-Activated Protein Kinase Kinase Kinase 14) (C-Term) (ABIN1030544)
Characteristics 17 amino acids near the carboxy terminus of human NIK.
Human
Research Area Transcription Factors
Application Notes NIK peptide is used for blocking the activity of NIK.
Restrictions For Research Use only
Format Liquid
Concentration 200 μg/mL
Buffer PBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1 % bovine serum albumin and 0.02 % sodium azide
Preservative Sodium azide
Precaution of Use This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Storage -20 °C
Expiry Date 12 months
Background publications Malinin, Boldin, Kovalenko, Wallach: "MAP3K-related kinase involved in NF-kappaB induction by TNF, CD95 and IL-1." in: Nature, Vol. 385, Issue 6616, pp. 540-4, 1997 (PubMed).

He, Chen, Farzan, Choe, Ohagen, Gartner, Busciglio, Yang, Hofmann, Newman, Mackay, Sodroski, Gabuzda: "CCR3 and CCR5 are co-receptors for HIV-1 infection of microglia." in: Nature, Vol. 385, Issue 6617, pp. 645-9, 1997 (PubMed).

Choe, Farzan, Sun, Sullivan, Rollins, Ponath, Wu, Mackay, LaRosa, Newman, Gerard, Gerard, Sodroski: "The beta-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates." in: Cell, Vol. 85, Issue 7, pp. 1135-48, 1996 (PubMed).